In the NASH Clinical Research Network, PAI-1 was associated with definite NASH in comparison with non-NASH (Odds ratio 1.2, 95% confidence interval 1.08–1.34, p < 0.001) (33). Here, SERPINE1 is linked to metabolic dysfunction-associated steatohepatitis.